Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | CTSG | P08311 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | GCGR | P47871 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | IAPP | P10997 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | PDE5A | O76074 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL548498 | 0.88 | ELANE (0.48) | HTR1AELANECTSGBCL2L1TSHR | |
| SCHEMBL30212610 | 0.88 | ELANE (0.48) | HTR1AELANECTSGBCL2L1TSHR | |
| SCHEMBL6704515 | 0.87 | PPARA (0.41) | HTR1AELANECTSGALDH1A1HPGD | |
| SCHEMBL28161120 | 0.86 | ELANE (0.53) | HTR1AELANECTSGCNR1CNR2 | |
| SCHEMBL324186 | 0.86 | ELANE (0.47) | HTR1AELANECTSGBCL2L1TSHR | |
| SCHEMBL983845 | 0.86 | LIPG (0.53) | ELANECTSGALOX5BCL2L1HSD17B10 | |
| SCHEMBL5588855 | 0.86 | ELANE (0.49) | HTR1AELANECTSGHSPA5ALDH1A1 | |
| SCHEMBL984108 | 0.85 | LIPG (0.56) | ELANECTSGALOX5BCL2L1HSD17B10 | |
| SCHEMBL982370 | 0.85 | LIPG (0.56) | ELANECTSGALOX5BCL2L1HSD17B10 | |
| SCHEMBL983656 | 0.85 | LIPG (0.56) | ELANECTSGALOX5BCL2L1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-115779493-A | Method for purifying liquid crystal monomer or liquid crystal composition by using functionalized silica gel material | 苏州硒诺唯新新材料科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| EP-2275405-B1 | PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE | ASAHI CHEMICAL IND (JP) | 2019-04-24 | — | — | EP | disclosed |
| EP-2275406-B1 | PROCESS FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2018-11-28 | — | — | EP | disclosed |
| EP-2792673-B1 | Carbamic acid ester derivatives for the production of isocyanate and aromatic hydroxy compounds | ASAHI CHEMICAL IND (JP) | 2018-07-25 | — | — | EP | disclosed |
| US-9685597-B2 | Curable composition for sealing optical semiconductor | DAICEL CORPORATION (JP) | 2017-06-20 | — | — | US | disclosed |
| US-9637445-B2 | Isocyanate production process using composition containing carbamic acid ester and aromatic hydroxy compound, and composition for transfer and storage of carbamic acid ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-05-02 | — | — | US | disclosed |
| EP-2147909-B1 | METHOD FOR PRODUCTION OF ISOCYANATE USING COMPOSITION COMPRISING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSPORT OR STORAGE OF CARBAMIC ACID ESTER | ASAHI CHEMICAL IND (JP) | 2016-12-14 | — | — | EP | disclosed |
| US-20160126431-A1 | CURABLE COMPOSITION FOR SEALING OPTICAL SEMICONDUCTOR | DAICEL CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| US-20100113823-A1 | ISOCYANATE PRODUCTION PROCESS USING COMPOSITION CONTAINING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSFER AND STORAGE OF CARBAMIC ACID ESTER | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2147909-A1 | METHOD FOR PRODUCTION OF ISOCYANATE USING COMPOSITION COMPRISING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSPORT OR STORAGE OF CARBAMIC ACID ESTER | Asahi Kasei Chemicals Corporation (JP) | 2010-01-27 | — | — | EP | disclosed |
| US-4157324-A | High ortho etherified resole resins admixed with coreactive resins | MONSANTO COMPANY (US) | 1979-06-05 | — | — | US | disclosed |
| US-4122235-A | LAMINATE, METAL SALT CURING ACCELERATOR | MONSANTO COMPANY (US) | 1978-10-24 | — | — | US | disclosed |
| US-4122054-A | High ortho etherified resole resins | MONSANTO COMPANY (US) | 1978-10-24 | — | — | US | disclosed |
| US-4120847-A | High ortho etherified resole resins | MONSANTO COMPANY (US) | 1978-10-17 | — | — | US | disclosed |
| US-4112188-A | LAMINATE, BORIC ACID, DIAMMONIUM TETRABORATE, DIAMMONIUM PENTABORATE, AND/OR DIAMMONIUM OCTABORATE AS ACCELERATORS | MONSANTO COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4045398-A | BORON COMPOUND CURING ACCELERATOR | MONSANTO COMPANY (US) | 1977-08-30 | — | — | US | disclosed |
| US-4043970-A | IMPROVED CURE RATE IN ELECTRICAL LAMINATES | MONSANTO COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
| US-4022942-A | NOVOLAKS OR B-STAGE RESINS | MONSANTO COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113823-A1 | ISOCYANATE PRODUCTION PROCESS USING COMPOSITION CONTAINING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSFER AND STORAGE OF CARBAMIC ACID ESTER | PAH, APEH, CPS1 | HTR1A 2960/4885ELANE 1749/4885CTSG 158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.